In this trial, we are evaluating the safety and tolerability of a new investigational DNA vaccine to protect against SARS CoV-2 virus. As you are aware, this virus has caused an outbreak of an illness called coronavirus disease-19 (called “COVID‑19”) around the world. In this study, it is the first time that this particular vaccine is given to humans.
This study will require 8 clinic visits and 2 telephone calls over a twelve month period.
To be eligible you must:
- Be a healthy male or healthy female who is not pregnant or who cannot bear children
- Aged 18-75 (inclusive)
If you meet the criteria for this study and would like more information, register below or call 1800 727 874.
To view the Media release for this trial, please click here.